admin

Municipals were firmer Tuesday amid a busy primary market with several large deals, as U.S. Treasury yields fell and equities ended up. The two-year muni-to-Treasury ratio Monday was at 68%, the three-year at 69%, the five-year at 71%, the 10-year at 70% and the 30-year at 86%, according to Refinitiv Municipal Market Data’s 3 p.m.
0 Comments
Hurricane Irma strikes Miami, Florida, in 2017. Warren Faidley | Getty Images Hurricane season has officially begun. With scientists predicting yet another active year for storms, making your home hurricane resistant has become a more valuable precaution. The National Oceanic and Atmospheric Administration said in its forecast May 23 that it expects an 85% chance
0 Comments
In this article TXN Follow your favorite stocksCREATE FREE ACCOUNT The Texas Instruments Inc. logo is seen on scientific calculator packages in Tiskilwa, Illinois. Daniel Acker | Bloomberg | Getty Images Company: Texas Instruments (TXN) Business: Texas Instruments is a global semiconductor company. The company designs, manufactures, tests and sells analog and embedded processing chips
0 Comments
Bangkok, Thailand has seen an 18.1% growth in residential rental prices on a year-on-year basis, according to JLL. Alexander Spatari | Moment | Getty Images Singapore and Hong Kong are generally considered Asia’s more vibrant real estate markets. But some up-and-coming cities are giving these traditional hubs a run for their money, with some even
0 Comments
The logo for Salesforce is displayed on the Salesforce Tower in New York City on March 7, 2019. Brendan Mcdermid | Reuters Check out the companies making headlines in extended trading: Salesforce — Shares plunged more than 14% after first-quarter revenue of $9.13 billion missed consensus estimates of $9.17 billion, according to LSEG. Adjusted earnings
0 Comments
In this article AZN-GB BMY LLY NVS NOV.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceuticals. The therapy essentially delivers radiation directly into tumors by
0 Comments